XML 74 R49.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Collaboration arrangements and concentration of credit risk - Chiesi (Details) $ in Thousands, € in Millions |  | 12 Months Ended
--- | --- | ---
Jun. 30, 2013 EUR (€) | Jun. 30, 2013 USD ($) | Dec. 31, 2016 USD ($) | Dec. 31, 2015 USD ($) | Dec. 31, 2014 USD ($)
Collaboration arrangements |  |  |  |  |
Collaboration revenues |  |  | $ 7,164 |  |
License revenues |  |  | 975 |  |
Chiesi Farmaceuticai S.p.A |  |  |  |  |
Collaboration arrangements |  |  |  |  |
Revenues from product sales |  |  | 0 | $ 300 | $ 0
Collaborative revenue | Chiesi Farmaceuticai S.p.A |  |  |  |  |
Collaboration arrangements |  |  |  |  |
Collaboration revenues |  |  | $ 7,200 | 4,900 | 5,000
Percentage of costs to be paid by counterparty |  |  | 50.00% |  |
Royalties percentage receivable |  |  | mid double digit |  |
Collaborative revenue | Chiesi Farmaceuticai S.p.A | Minimum |  |  |  |  |
Collaboration arrangements |  |  |  |  |
Estimated percentage of sales by counterparty to be retained by reporting entity |  |  | 25.00% |  |
Collaborative revenue | Chiesi Farmaceuticai S.p.A | Maximum |  |  |  |  |
Collaboration arrangements |  |  |  |  |
Estimated percentage of sales by counterparty to be retained by reporting entity |  |  | 35.00% |  |
License revenue | Chiesi Farmaceuticai S.p.A |  |  |  |  |
Collaboration arrangements |  |  |  |  |
Up-front payment received | € 17.0 | $ 22,100 |  |  |
License revenues |  |  | $ 1,000 | $ 1,000 | $ 1,200

X
- Definition Revenue earned during the period relating to collaboration arrangement. + References No definition available. + Details
Name: | qure_CollaborationRevenue
Namespace Prefix: | qure_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The percentage of costs that counterparty has agreed to pay, and for which the reporting entity recognizes as collaboration revenue. + References No definition available. + Details
Name: | qure_CollaborativeArrangementCostSharingPercentage
Namespace Prefix: | qure_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The estimated percentage of sales by the counterparty that is expected to be retained by the reporting entity, net of manufacturing costs, third-party royalties, and related amounts. + References No definition available. + Details
Name: | qure_EstimatedPercentageOfSalesByCounterpartyToBeRetainedByReportingEntity
Namespace Prefix: | qure_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The royalty percentage receivable by the reporting entity under the license agreement. + References No definition available. + Details
Name: | qure_LicenseAgreementRoyaltiesPercentageReceivable
Namespace Prefix: | qure_
Data Type: | us-types:durationStringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The up-front payment received as of the effective date of the collaboration agreement, + References No definition available. + Details
Name: | qure_UpfrontPaymentReceived
Namespace Prefix: | qure_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_LicensesRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_SalesRevenueGoodsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_CounterpartyNameAxis=qure_ChiesiFarmaceuticaiS.p.aMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=qure_CollaborativeArrangementRevenueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=qure_CollaborativeArrangementLicenseRevenueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |